KLP Kapitalforvaltning AS bought a new stake in Oscar Health, Inc. ( NYSE:OSCR – Free Report ) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 33,900 shares of the company’s stock, valued at approximately $456,000.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. KBC Group NV grew its holdings in shares of Oscar Health by 56.1% during the fourth quarter.
KBC Group NV now owns 7,107 shares of the company’s stock worth $96,000 after buying an additional 2,555 shares in the last quarter. ORG Wealth Partners LLC purchased a new stake in Oscar Health in the 4th quarter worth approximately $100,000. Alberta Investment Management Corp purchased a new stake in Oscar Health in the 4th quarter worth approximately $138,000.
Virtu Financial LLC acquired a new position in Oscar Health in the 4th quarter valued at $140,000. Finally, SMART Wealth LLC purchased a new position in shares of Oscar Health during the 4th quarter worth $180,000. Hedge funds and other institutional investors own 75.
70% of the company’s stock. Wall Street Analyst Weigh In Several equities analysts recently weighed in on OSCR shares. Jefferies Financial Group started coverage on Oscar Health in a research report on Tuesday, December 10th.
They set an “underperform” rating and a $12.00 target price on the stock. Wells Fargo & Company lowered shares of Oscar Health from an “overweight” rating to an “equal weight” rating and cut their price objective for the stock from $20.
00 to $16.00 in a report on Thursday, March 13th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company.
Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $20.21. Oscar Health Stock Performance NYSE OSCR opened at $12.
99 on Friday. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.
73 and a quick ratio of 0.73. Oscar Health, Inc.
has a 1-year low of $12.25 and a 1-year high of $23.79.
The business’s 50-day simple moving average is $14.60 and its 200-day simple moving average is $15.84.
The firm has a market capitalization of $3.25 billion, a P/E ratio of -649.18 and a beta of 1.
75. Oscar Health ( NYSE:OSCR – Get Free Report ) last announced its quarterly earnings results on Tuesday, February 4th. The company reported ($0.
62) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07).
Oscar Health had a return on equity of 2.28% and a net margin of 0.28%.
Equities analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current year.
About Oscar Health ( Free Report ) Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Recommended Stories Five stocks we like better than Oscar Health The How And Why of Investing in Oil Stocks Archer Aviation’s Africa Deal Could Boost ACHR Stock Quiet Period Expirations Explained Are Short Sellers Wrong About These 3 Semiconductor Stocks? What is the Nikkei 225 index? Boeing Gets $50B in March Orders—Is BA Stock a Buy Now? Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter ..
Business
KLP Kapitalforvaltning AS Invests $456,000 in Oscar Health, Inc. (NYSE:OSCR)

KLP Kapitalforvaltning AS bought a new stake in Oscar Health, Inc. (NYSE:OSCR – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 33,900 shares of the company’s stock, valued at approximately $456,000. Other institutional investors and hedge funds have [...]